|Status : Upcoming||Report Code : VRHC1018||Industry : Healthcare||Available Format :|
Industry Insights by Detection Method (Dye-Based, and Probes and Primer-Based), by Packaging Type (qPCR Core Kits and qPCR Mastermixes), by Application (Diagnostic, Research and Forensic), by End-User (Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations and Forensic Laboratories)
Qualitative polymerase chain reaction (qPCR) reagent is the mixture used in the qPCR technique to quantitate DNA sequence in a sample to synthesis new strands of DNA. It is also known as real-time polymerase chain reaction. The global qPCR reagents market is growing at significant rate due to mounting occurrence of infectious diseases and genetic disorders, technological improvement and speedy progression in geriatric population. The market has witnessed high demand for qPCR core kits over the last few years, due to low prices of core kits.
Insight by Detection Method
There are two types of detection methods for qPCR reagents, dye-based, and probes and primer-based. Of both probe and primer based detection method is expected to grow at the faster rate in the market due to its benefits over the dye based such as more exact than dye based.
Insight by Packaging Type
On the basis of packaging type, the qPCR reagents market is subdivided into qPCR core kits and qPCR mastermixes. qPCR core kit account for the largest share in the market due to boosting market accessibility of core kits across major countries, minimal prices of core kits, expanding private-public finance for life science research, and suppleness offered to end users.
Insight by Application
The global qPCR reagents market has also been subdivided by application into diagnostic applications, research applications, and forensic applications. The forensic application is expected to grow at the fastest rate in the market due to mounting frequencies of criminal cases, and boosting laboratory automation in forensic laboratories.
Insight by End-User
On the basis of end-users, qPCR reagents market is subdivided into diagnostic centers, forensic laboratories, research laboratories & academic institutes, clinical research organizations (CROs) and pharmaceutical & biotechnology companies. The hospitals and diagnostic centers are the largest end-user in the qPCR reagents market due to reinforcing healthcare infrastructure for effective disease diagnosis & treatment, expanding number of product introduced for diagnostic applications, and advantages offered by qPCR in disease diagnosis.
The mounting occurrence of infectious diseases and genetic disorders, speedy upsurge in aging population, mounting demand for drug discovery and pharmacogenomics, and technological development in life sciences sector are the primary growth drivers for qPCR reagents market. For instance, according to the World Health Organization (WHO), globally in 2016 approximately 10.4 million people were suffering with tuberculosis and approximately 1.7 million people die from the disease. Moreover, according to WHO in 2015 approximately 887,000 deaths occurred due to complications of hepatitis B and in 2016 approximately one million people died from HIV related causes.
Expanding private-public grants, assets and investments for qPCR research and shift from plant originated to genome based drug discovery are also fueling the growth of the qPCR reagents market. Mounting market diffusion in emerging countries and effective accomplishment of human genome project are also driving the growth of the market.
The technical inadequacies associated with qPCR, elevated setting-up and reagents refill price, and acceptance and implementation of Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines for issuing qPCR-based research are the major challenges for the growth of qPCR reagents market.
The qPCR reagents market is highly regulated and requires intensive capital for the entry. Moreover, the competition among the players is increasing as the demand for technologically advanced products is increasing.
Geographically, North America is the largest qPCR reagents market as the region is home to large number of industry players. Some of the other factors leading to the growth of the North American market are elevated dispersion of qPCR technologies among end users, mounting public & private grant to magnify the application base of qPCR, continuing product advancements, and constant decrease in the average price of genome sequencing.
Asia-Pacific is observed to witness the fastest growth in the market as the region comprises of largest population. In addition, escalating occurrence of infectious disease and genetic disorder, expanding geriatric population, growing initiatives to enhance awareness associated to gene-based disease treatment, mounting frequencies of criminal cases, growing intensity of global life sciences industries, and mounting private and public support to enlarge innovative digital PCR technologies, are also creating a positive impact on the qPCR reagents industry growth in the region.
Key players in the industry are investing in the development of innovative and advance quantitative polymerase chain reaction reagents products, which is strengthening their position in the market. Thermo Fisher Scientific, Bio-Rad Laboratories Inc., and Qiagen N.V. together accounted major share of the qPCR reagents market. For instance, In March 2018, Thermo Fisher Scientific Inc., acquired IntegenX Inc., to enhance its product portfolio. IntegenX Inc, is a company which offers a speedy DNA platform for usage in forensics and law implementation applications.
In addition, in April 2018, QIAGEN N.V. launched QIAstat-Dxâ an integrated molecular analysis of common syndromes as tested for in syndromes in infections, oncology and other diseases in Europe. Thermo Fisher Scientific Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Takara Bio Inc., F. Hoffman-La Roche Ltd., Promega Corporation, Qiagen N.V., Agilent Technologies, Inc., Sigma-Aldrich Corporation, and Quanta Biosciences, Inc. are some of the key players offering qPCR reagents products.